EGFR and non-small cell lung carcinoma: We then probed the synergistic effect of ALK and ERBB loss either by chemical inhibition or knockdown in NSCLC cell lines, which led to a significant reduction of cell proliferation and survival in EML4-ALK + NSCLC cell lines only.